115 results on '"Klajnert, Barbara"'
Search Results
2. Complexation of HIV derived peptides with carbosilane dendrimers
3. Dendrimers reduce toxicity of Aβ 1-28 peptide during aggregation and accelerate fibril formation
4. The influence of maltose modified poly(propylene imine) dendrimers on hen egg white lysozyme structure and thermal stability
5. Haemolytic activity of polyamidoamine dendrimers and the protective role of human serum albumin
6. Characterization of complexes formed by polypropylene imine dendrimers and anti-HIV oligonucleotides
7. Interaction of cationic phosphorus dendrimers (CPD) with charged and neutral lipid membranes
8. New Drug Delivery Nanosystem Combining Liposomal and Dendrimeric Technology (Liposomal Locked-In Dendrimers) for Cancer Therapy
9. Modulation of biogenic amines content by poly(propylene imine) dendrimers in rats
10. Effect of amyloid beta peptides Aβ1–28 and Aβ25–40 on model lipid membranes
11. Binding Properties of Water-Soluble Carbosilane Dendrimers
12. Contribution of hydrophobicity, DNA and proteins to the cytotoxicity of cationic PAMAM dendrimers
13. Interactions between PAMAM dendrimers and bovine serum albumin
14. Modified PAMAM dendrimer with 4-carbomethoxypyrrolidone surface groups reveals negligible toxicity against three rodent cell-lines
15. Surface modification of PAMAM dendrimer improves its biocompatibility
16. Enhancement of antimicrobial activity by co-administration of poly(propylene imine) dendrimers and nadifloxacin.
17. Phosphorus Dendrimers as Carriers of siRNA--Characterisation of Dendriplexes.
18. Stability of DendriplexesFormed by Anti-HIV Genetic Material and Poly(propylene imine) Dendrimersin the Presence of Glucosaminoglycans.
19. Antimicrobial activity of poly(propylene imine) dendrimers.
20. Influence of fourth generation poly(propyleneimine) dendrimers on blood cells.
21. Impact of maltose modified poly(propylene imine) dendrimers on liver alcohol dehydrogenase (LADH) internal dynamics and structure.
22. Characteristics of complexes between poly(propylene imine) dendrimers and nucleotides.
23. Genotoxicity of poly(propylene imine) dendrimers.
24. Influence of dendrimers on red blood cells.
25. In vivo toxicity of poly(propyleneimine) dendrimers.
26. Time Evolution of the Aggregation Process of Peptides Involved in Neurodegenerative Diseases and Preventing Aggregation Effect of Phosphorus Dendrimers Studied by EPR.
27. Metabolic limitations of the use of nucleoside analogs in cancer therapy may be overcome by application of nanoparticles as drug carriers: A review.
28. Effect of amyloid beta peptides Aβ1–28 and Aβ25–40 on model lipid membranes.
29. Interactions between dendrimers and heparin and their implications for the anti-prion activity of dendrimers.
30. The Influence of Densely Organized Maltose Shells on the Biological Properties of Poly(propylene imine) Dendrimers: New Effects Dependent on Hydrogen Bonding.
31. Influence of phosphorus dendrimers on the aggregation of the prion peptide PrP 185–208
32. EPR Study of the Interactions between Dendrimers and Peptides Involved in Alzheimer's and Prion Diseases.
33. Cytotoxicity, haematotoxicity and genotoxicity of high molecular mass arborescent polyoxyethylene polymers with polyglycidol-block-containing shells
34. Influence of heparin and dendrimers on the aggregation of two amyloid peptides related to Alzheimer’s and prion diseases
35. BIO-Dendrimer 2008: Symposium on biomedical properties and applications of dendrimers – Lodz, Poland.
36. Interaction of cationic carbosilane dendrimers and their complexes with siRNA with erythrocytes and red blood cell ghosts.
37. Effect of viologen–phosphorus dendrimers on acetylcholinesterase and butyrylcholinesterase activities
38. Poly(propylene imine) dendrimers modified with maltose or maltotriose protect phosphorothioate oligodeoxynucleotides against nuclease activity
39. siRNA carriers based on carbosilane dendrimers affect zeta potential and size of phospholipid vesicles
40. Effect of phosphorus dendrimers on DMPC lipid membranes
41. Cationic carbosilane dendrimers–lipid membrane interactions
42. The influence of PAMAM-OH dendrimers on the activity of human erythrocytes ATPases
43. Interactions of phosphorus-containing dendrimers with liposomes
44. Dendrimer–protein interactions studied by tryptophan room temperature phosphorescence
45. The influence of maltotriose-modified poly(propylene imine) dendrimers on the chronic lymphocytic leukemia cells in vitro: dense shell G4 PPI.
46. Interaction between polyamidoamine (PAMAM) dendrimers and bovine insulin.
47. Stability of dendriplexes formed by anti-HIV genetic material and poly(propylene imine) dendrimers in the presence of glucosaminoglycans.
48. Phosphorus dendrimers affect Alzheimer's (Aβ1-28) peptide and MAP-Tau protein aggregation.
49. Biological properties of new viologen-phosphorus dendrimers.
50. Carbosilane dendrimers are a non-viral delivery system for antisense oligonucleotides: characterization of dendriplexes.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.